1.
Jackson EB, Hotte SJ. Disparity in public funding of systemic therapy for metastatic renal cell carcinoma within Canada. CUAJ [Internet]. 2022 Jun. 9 [cited 2024 Apr. 25];16(11):E516-22. Available from: https://cuaj.ca/index.php/journal/article/view/7846